UNSPSC 51301905: Chlormidazole hydrochloride

This classification denotes an antifungal agent with the molecular formula C15H13ClN2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0RH29TB951, chemically known as benzimidazole, 1-(p-chlorobenzyl)-2-methyl-, hydrochloride but more generally known as chlormidazole hydrochloride, which bears US NIH Compound Identifier 53015. European Medicines Agency schedules Chlormidazole hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13329MIG.

Most nations, for tariff and trade purposes, schedule chlormidazole hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, CHLORMIDAZOLE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC1NC2CCCCC2N1CC3CCC(CC3)CL.CL.

UNSPSC 51301905 Chlormidazole hydrochloride is a Commodity code that does not align with the recent state and local opportunities posted under it. The two most recent solicitations — a City of Austin IFB for liquid aluminum sulfate (alum) for wastewater treatment and a City of Tampa ITB for medical aid supplies (bandages, antiseptic sprays, pain relievers, and first aid kits) — fall outside the scope of this pharmaceutical intermediate chemical. The code shows little relevant recent activity aligned with its nominal commodity.

The mismatch between the code designation and the actual procurements posted under it suggests either a tagging error in the underlying procurement records or a data integrity issue. Business development professionals should verify the correct UNSPSC codes for any opportunities of actual interest before pursuing the City of Austin's August 25, 2026 alum solicitation or the City of Tampa's medical supply procurement.